Shape Memory Medical
San Jose, US · Delaware corporation · 50 employees on LinkedIn · 3 known investors
Founders & leadership
DM
Duncan MaitlandinFounder
MH
Michael HensoninExecutive
EF
Edward F. Ruppel, JrExecutive
CM
Carolyn M. BrugueraExecutive
JY
James Y LancasterinExecutive
Board
TR
Thom RascheBoard director
TT
Thomas ThalerBoard director
CK
Carla Kikken-JussenBoard director
JH
Jonathan HartmanBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$81.3M disclosed across 8 rounds · 2014–2026
▶$6.9MraisedJul 2026 · 16 investors · Other Health CareRule 506(b)
▶$6.9MraisedJul 2026 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. Ruppel, JrExecutive Officer, Director
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Duncan MaitlandDirector
- Thom RascheDirector
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6.9M
- Minimum investment
- $25K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedMay 2026 · 44 investors · Other Health CareRule 506(b)
▶$17MraisedMay 2026 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thom RascheDirector
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Edward F. Ruppel, JrExecutive Officer, Director
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $25K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.5MraisedFeb 2024 · 73 investors · Other Health CareRule 506(b)
▶$30.5MraisedFeb 2024 · 73 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $37.8M
- Amount sold
- $30.5M
- Minimum investment
- $24.7K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedApr 2023 · 37 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2023 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Thomas ThalerDirector
- Duncan MaitlandDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $4.8M
- Minimum investment
- $2.8K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5MraisedJul 2022 · 37 investors · Other Health CareRule 506(b)
▶$11.5MraisedJul 2022 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas ThalerDirector
- Edward RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Michael HensonDirector
- Offering amount
- $19.5M
- Amount sold
- $11.5M
- Minimum investment
- $15.8K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedAug 2017 · 15 investors · Other Health CareRule 506(b)
▶$7MraisedAug 2017 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carolyn M. BrugueraExecutive Officer
- Thomas ThalerDirector
- Michael HensonDirector
- Jim GamettDirector
- Edward F. Ruppel, Jr.Executive Officer, Director
- Duncan MaitlandDirector
- Offering amount
- $14M
- Amount sold
- $7M
- Minimum investment
- $7.5K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3MraisedApr 2016 · 12 investors · Other Health CareRule 506(b)
▶$3MraisedApr 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James Y. LancasterExecutive Officer
- Duncan MaitlandExecutive Officer, Director
- Edward F. RuppelExecutive Officer, Director
- Michael HensonDirector
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $28K
- First sale
- Apr 2016
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$616.5KraisedJan 2015 · 10 investors · Other Health CareRule 506(b)
▶$616.5KraisedJan 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Duncan MaitlandExecutive Officer, Director
- James Y LancasterExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $616.5K
- First sale
- Dec 2014
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapSparta Biomedical5 shared keywordsSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.
Verse Medical5 shared keywordsVerse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
Companies competing with Shape Memory Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $199.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Gsmedtechgsmedtech.com · Aug 2026
August Global Partners leads $10m round for US medical device companydealstreetasia.com · Aug 2026
Shape Memory Medical secures $10m to advance aortic clinical trialshospitalmanagement.net · Aug 2026
Shape Memory Medical Raises $10 Million to Fund Aortic Device Trials — BigGo Financefinance.biggo.com · Aug 2026Frequently asked questions
- Who founded Shape Memory Medical?
- Shape Memory Medical was founded by Duncan Maitland.
- Who are Shape Memory Medical's investors?
- Shape Memory Medical's investors include Emergent Medical Partners, LLP, Earlybird Venture Capital, Taiwania Capital.
- How much funding has Shape Memory Medical raised?
- Shape Memory Medical has disclosed $81.3M raised across 8 rounds.
- Where is Shape Memory Medical headquartered?
- Shape Memory Medical is headquartered in San Jose, US.